Type 1 diabetes

Mauriac Syndrome in Sudanese Children: An Old Syndrome Still Existing in Resource‐Limited Countries

Pediatr DiabetesPublished Cross-sectional study

Authors' conclusion

Despite many efforts that have been made to achieve better glycemic control in children with T1DM, MS still exists in our setting. Though liver biopsy is the gold standard for diagnosis, being invasive, the diagnosis could be made conservatively, based on clinical features and response to treatment. The condition can be reversed with good metabolic control.

Study context

Population
Sudanese children and adolescents with Mauriac syndrome due to inadequate diabetes control (T1D or neonatal diabetes), single centre
Participants
37 children
Outcome
Magnitude, clinical features, management and outcome of Mauriac syndrome
Methodological detailshospital-based, medical record review, Patients were re-educated, management intensified, then followed up
  • Hospital-based
  • Medical record review
  • Patients were re-educated, management intensified, then followed up

Main finding

As reported in the abstract

Outcome after re-education and intensified management

Improved (decrease in liver size with or without increased growth velocity)

21

56.8%

Static condition

7

18.9%

Lost to follow-up

8

21.6%

Died

1

2.7%

Observational data: associations, not effects.

Further findings

Patient characteristics

Male
59.5%
Neonatal diabetes (others T1D)
5.4%
Median age at mauriac syndrome (MS) diagnosis
12 years
Diagnosis based solely on clinical findings (prolonged poor glycemic control, short stature, hepatomegaly)

Associated complications

Nephropathy, the most common associated complication; some at a very young age
33.3%

Original publication

Mauriac Syndrome in Sudanese Children: An Old Syndrome Still Existing in Resource‐Limited Countries. Pediatr Diabetes. Published 26 August 2025. doi:10.1155/pedi/7047312

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.